The European Commission published an updated frequently-asked Q&A (Version 12) regarding the implementation of the rules
on the safety features for medicinal products for human use. The 28-page Q&A includes definitions, requirements, and exemptions
addressing unique identifier and anti-tampering elements of drug labelling and packaging.
[membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
